These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Pulmonary infection and antibiotic treatment in patients with cystic fibrosis. Kerrebijn KF; Mouton J Acta Univ Carol Med (Praha); 1990; 36(1-4):28-33. PubMed ID: 2130712 [No Abstract] [Full Text] [Related]
26. [Pseudomonas aeruginosa and mucoviscidosis]. Lenoir G Rev Pneumol Clin; 1995; 51(3):151-9. PubMed ID: 7569577 [TBL] [Abstract][Full Text] [Related]
27. Clinical presentation of metabolic alkalosis in an adult patient with cystic fibrosis. Sweetser LJ; Douglas JA; Riha RL; Bell SC Respirology; 2005 Mar; 10(2):254-6. PubMed ID: 15823195 [TBL] [Abstract][Full Text] [Related]
28. Cystic fibrosis infections: treatment strategies and prospects. George AM; Jones PM; Middleton PG FEMS Microbiol Lett; 2009 Nov; 300(2):153-64. PubMed ID: 19674113 [TBL] [Abstract][Full Text] [Related]
29. Clinical impact of reducing routine susceptibility testing in chronic Pseudomonas aeruginosa infections in cystic fibrosis. Etherington C; Hall M; Conway S; Peckham D; Denton M J Antimicrob Chemother; 2008 Feb; 61(2):425-7. PubMed ID: 18156280 [TBL] [Abstract][Full Text] [Related]
30. Novel approach to the eradication of Pseudomonas aeruginosa in an infant with CF after outpatient treatment failure. Hayes D; Kanga JF; Anstead MI; Kuhn RJ Pediatr Pulmonol; 2008 May; 43(5):511-3. PubMed ID: 18383117 [TBL] [Abstract][Full Text] [Related]
31. Regimens for eradicating early Pseudomonas aeruginosa infection in children do not promote antibiotic resistance in this organism. Ho SA; Lee TW; Denton M; Conway SP; Brownlee KG J Cyst Fibros; 2009 Jan; 8(1):43-6. PubMed ID: 18829398 [TBL] [Abstract][Full Text] [Related]
32. Antibiotic treatment of cystic fibrosis. Jedlicková Z; Vávrová V; Houstĕk J; Výmola F Acta Univ Carol Med (Praha); 1990; 36(1-4):42-3. PubMed ID: 2130716 [No Abstract] [Full Text] [Related]
34. Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety. Geller DE; Konstan MW; Smith J; Noonberg SB; Conrad C Pediatr Pulmonol; 2007 Apr; 42(4):307-13. PubMed ID: 17352404 [TBL] [Abstract][Full Text] [Related]
35. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients. Murray TS; Egan M; Kazmierczak BI Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667 [TBL] [Abstract][Full Text] [Related]
36. [How should initial colonization by Pseudomonas aeruginosa be treated in patients with cystic fibrosis?]. David V Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S113-7. PubMed ID: 12910143 [No Abstract] [Full Text] [Related]
37. Eradication of early Pseudomonas infection in cystic fibrosis. Lee TW Chron Respir Dis; 2009; 6(2):99-107. PubMed ID: 19411571 [TBL] [Abstract][Full Text] [Related]
38. Prophylactic antibiotics in cystic fibrosis: a conviction without evidence? Smyth A Pediatr Pulmonol; 2005 Dec; 40(6):471-6. PubMed ID: 16200640 [TBL] [Abstract][Full Text] [Related]
39. Acute lymphoblastic leukemia in a 10-year-old boy with cystic fibrosis - improvement of pulmonary function during chemotherapy in spite of intermittent Pseudomonas aeruginosa colonisation. Dopfer C; Kentouche K; Gruhn B; Dopfer R; Becker S; Mentzel HJ; Beck JF; Mainz JG Klin Padiatr; 2011 Nov; 223(6):368-9. PubMed ID: 22012603 [No Abstract] [Full Text] [Related]
40. Emergence of carbapenem resistance in Pseudomonas aeruginosa isolates from a patient with cystic fibrosis in the absence of carbapenem therapy. Wolter DJ; Acquazzino D; Goering RV; Sammut P; Khalaf N; Hanson ND Clin Infect Dis; 2008 Jun; 46(12):e137-41. PubMed ID: 18462098 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]